Effectiveness of colchicine for the treatment of long COVID

JAMA Internal Medicine

2025-10-20

(Press-News.org) About The Study: In this randomized clinical trial, among adults with long COVID, colchicine did not improve functional capacity, respiratory function, or inflammatory markers. These findings underscore the need to explore alternative therapeutic approaches for long COVID.

Corresponding Author: To contact the corresponding author, Niveditha Devasenapathy, PhD, MBBS, MSc, email ndevasenapathy@georgeinstitute.org.in.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamainternmed.2025.5408)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.5408?guestAccessKey=fd6ee457-d207-428f-911c-27d7ea7cace8&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102025

END

ELSE PRESS RELEASES FROM THIS DATE:

Distance to care and telehealth abortion demand after Dobbs

2025-10-20

About The Study: Overall, this study observed a doubling in monthly telehealth medication abortion requests across 18 states post-Dobbs, with most requests occurring before 6 weeks of pregnancy and the highest rates among individuals living further from in-person abortion care. These results build upon the researcher’s findings pre-Dobbs, which also demonstrated increased telehealth medication abortion requests among individuals living further from brick-and-mortar facilities. Corresponding Author: To contact the corresponding author, Amy K. Willerford, MPH, email amykw@uw.edu. To access the embargoed study: Visit ...

Epidural electrical stimulation for functional recovery in incomplete spinal cord injury

2025-10-20

Spinal cord injury (SCI) causes paralysis in roughly one million people worldwide, with incident cases rising yearly. Beyond motor and sensory deficits, patients frequently experience muscle atrophy, spasticity, heterotopic ossification, and autonomic dysfunction, all of which severely impair quality of life. Current treatments are rehabilitation-centered; medications, physical therapies, and surgery rarely reverse neural damage. In recent years, epidural electrical stimulation (EES) has emerged as a neurorehabilitation approach. Prior animal and clinical studies suggest that EES, delivered via electrodes implanted ...

Transformative eye research expands donor pool for corneal transplant patients

2025-10-20

CLEVELAND—Many eye banks won’t accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail. But a new study led by researchers at Case Western Reserve University and University Hospitals suggests otherwise. The results, published Oct. 17 in the journal JAMA Ophthalmology, found no significant differences in patients who received corneas from donors with diabetes than from those without the disease one year after the surgery. The implication is that the number of corneas available for transplant worldwide could be ...

Retinal implant restores central vision in patients with advanced AMD, study co-led by Pitt investigator shows

2025-10-20

PITTSBURGH, October 20, 2025 – A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published today in the New England Journal of Medicine. Advanced atrophic AMD, also known as geographic atrophy (GA), is the leading cause of irreversible blindness in older adults, affecting more than 5 million people worldwide. The international, multi-center trial was co-led by José-Alain Sahel, M.D., director of the UPMC Vision ...

Eye prosthesis is the first to restore sight lost to macular degeneration

2025-10-20

A tiny wireless chip implanted in the back of the eye and a pair of high-tech glasses have partially restored vision to people with an advanced form of age-related macular degeneration. In a clinical trial led by Stanford Medicine researchers and international collaborators, 27 out of 32 participants had regained the ability to read a year after receiving the device. With digital enhancements enabled by the device, such as zoom and higher contrast, some participants could read with acuity equivalent to 20/42 vision. The results of the trial will be published Oct. 20 in the New England Journal of Medicine. The ...

Pioneering eye device restores reading vision to blind eyes

2025-10-20

After being treated with an electronic eye implant paired with augmented-reality glasses, people with sight loss have recovered reading vision, reports a trial involving a UCL (University College London) and Moorfields Eye Hospital clinical researcher. The results of the European clinical trial, published in The New England Journal of Medicine, showed 84% of participants were able to read letters, numbers and words using prosthetic vision through an eye that had previously lost its sight due to the untreatable ...

Subretinal implant partially restores vision in AMD patients

2025-10-20

Age-related macular degeneration (AMD) causes progressive vision loss in many elderly people, and no treatment is available for the so-called atrophic form of the disease. A neurostimulation system called Prima, including a subretinal implant, could change all that. The results of a clinical trial involving Inserm, Sorbonne University and CNRS - via the Institut de la vision -, the Hôpital Fondation Adolphe de Rothschild and the Hôpital national des 15-20 show that it partially restored sight in over 80% of participants with AMD, who recovered their ability to read letters, numbers and words. The results are published in the New England journal of medicine. Age-related macular ...

3D printed antenna arrays developed for flexible wireless systems

2025-10-20

PULLMAN, Wash. – Washington State University-led researchers have developed a chip-sized processor and 3D printed antenna arrays that could someday lead to flexible and wearable wireless systems and improved electronic communications in a wide variety of auto, aviation, and space industry applications. Reporting in the journal Nature Communications, the researchers used 3D printing, the processor, and an ink made from copper nanoparticles to create the flexible antenna arrays. “This proof-of-concept prototype paves the way ...

When is the brain like a subway station? When it’s processing many words at once

2025-10-20

Trains move through the world’s subway stations in a consistent pattern: arriving, stopping, and moving to the next stop—and repeated by other trains throughout the day. A new study by a team of New York University psychology and linguistics researchers finds that our brains work much the same way when processing several words at once—as we routinely do when listening to others speak. The work, which uncovers new ways the brain functions, appears in the journal Proceedings of the National Academy ...

Important phenomenon discovered in the Arctic – could boost marine life

2025-10-20

The shrinking sea ice in the Arctic Ocean is, overall, a disaster. But paradoxically, the melting of the ice can also fuel the engine of the Arctic food chains: algae. Algae are the main food source for life in the sea, but they need nitrogen to grow. And nitrogen is in short supply in the Arctic Ocean. However, a new international study led by the University of Copenhagen indicates therewill probably be more of it in the future than previously thought. This could change the future prospects for marine life in the High North and possibly for the carbon budget. The researchers ...

LAST 30 PRESS RELEASES:

Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma (version 2024)